Cite

HARVARD Citation

    French, J. et al. (2021). Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy. Neurology. pp. e1757-e1767. [Online]. 
  
Back to record